Masimo develops patient monitoring technologies and automation solutions worldwide. The company offers pulse oximetry with motion and low perfusion monitoring. Their rainbow SET platform includes products for noninvasive monitoring of various health metrics. They also provide brain function, hemodynamic, and regional oximetry monitoring solutions. Additionally, Masimo offers hospital automation platforms, including patient safety features. Products are sold through direct sales, distributors, and original equipment manufacturers. The company was incorporated in 1989 and is headquartered in Irvine, California.
Indicator | Value |
---|---|
PER | 100.0 |
EV/EBITDA | 62.5 |
Price/Free Cash Flow' | 58.6 |
ROIC | 10.8% |
Net Debt/EBITDA | 4.0 |